Last updated: October 29, 2021
Sponsor: Silkiss Eye Surgery
Overall Status: Completed
Phase
2/3
Condition
Progressive Supranuclear Palsy
Dystonias
Dyskinesias
Treatment
N/AClinical Study ID
NCT04423341
1268646
Ages > 18 All Genders Accepts Healthy Volunteers
Study Summary
Eligibility Criteria
Inclusion
Inclusion Criteria:
- Patients in the private practice of the principal investigator with an ICD code of "blepharospasm" and:
- undergoing routine maximal botulinum therapy
- experiencing break through symptoms of spasm
- marijuana naïve
Exclusion
Exclusion Criteria:
- concomitant diagnosis of epilepsy
- patients whom are not marijuana naive
- patients on concurrent anti-epileptics
- patients who are pregnant or wishing to become pregnant
- patients not wishing to participate in the study.
Study Design
Total Participants: 12
Study Start date:
May 20, 2020
Estimated Completion Date:
October 01, 2021
Connect with a study center
Silkiss Eye Surgery
Oakland, California 94609
United StatesSite Not Available
Not the study for you?
Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.